Browse experiments

Examples: survivin siRNA, R9, TAT, GGACGAGGACGAGCACUUCTT

Download filtered results Clear

First Previous 1 ... 17 18 19 20 21 ... 26 Next Last

Page 19 of 26 (2582 experiments total, 100 per page)

Experiment Paper Year Peptide RNA type Uptake confirmed In vitro functional effect Endosomal escape evidence In vivo Success class
EXP001801 Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-… 2021 GALA + CREKA (dual CPP) — GC-NP/siEGFR siRNA yes yes yes no no
EXP001802 Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-… 2021 GALA + CREKA (dual CPP) — GC-NP/siBRD4 siRNA yes yes yes no no
EXP001803 Serum Stability and Physicochemical Characterization of a Novel Amphipathic Pep… 2014 C6M1 siRNA no yes no no
EXP001804 A Dual-Ligand Liposomal System Composed of a Cell-Penetrating Peptide and a Mit… 2016 R8-modified MITO-Porter (no RNA aptamer) aptamer yes no no no
EXP001805 A Dual-Ligand Liposomal System Composed of a Cell-Penetrating Peptide and a Mit… 2016 RP/R8-modified MITO-Porter (2.5 mol% Chol-RP) aptamer yes no no no
EXP001806 A Dual-Ligand Liposomal System Composed of a Cell-Penetrating Peptide and a Mit… 2016 MRP/R8-modified MITO-Porter (2.5 mol% Chol-MRP) aptamer yes no no no
EXP001807 A Dual-Ligand Liposomal System Composed of a Cell-Penetrating Peptide and a Mit… 2016 D-arm/R8-modified MITO-Porter (2.5 mol% Chol-D-arm) aptamer yes no no no
EXP001808 Effective In Vivo Topical Delivery of siRNA and Gene Silencing in Intact Cornea… 2019 Chol-POD / siRNA polyplex siRNA yes no no no
EXP001809 Effective In Vivo Topical Delivery of siRNA and Gene Silencing in Intact Cornea… 2019 Palm-POD / siRNA polyplex siRNA yes no no no
EXP001810 Effective In Vivo Topical Delivery of siRNA and Gene Silencing in Intact Cornea… 2019 PLGA-PEG-POD / siRNA polyplex siRNA yes no no no
EXP001811 Effective In Vivo Topical Delivery of siRNA and Gene Silencing in Intact Cornea… 2019 POD / siRNA polyplex siRNA yes no no no
EXP001812 Effective In Vivo Topical Delivery of siRNA and Gene Silencing in Intact Cornea… 2019 Chol-POD + chloroquine / siRNA polyplex siRNA yes yes yes no no
EXP001813 Effective In Vivo Topical Delivery of siRNA and Gene Silencing in Intact Cornea… 2019 Palm-POD + chloroquine / siRNA polyplex siRNA yes yes yes no no
EXP001814 Effective In Vivo Topical Delivery of siRNA and Gene Silencing in Intact Cornea… 2019 PLGA-PEG-POD + chloroquine / siRNA polyplex siRNA yes yes yes no no
EXP001815 Effective In Vivo Topical Delivery of siRNA and Gene Silencing in Intact Cornea… 2019 POD + chloroquine / siRNA polyplex siRNA yes yes yes no no
EXP001816 Effective In Vivo Topical Delivery of siRNA and Gene Silencing in Intact Cornea… 2019 QN-Palm-POD / siRNA polyplex siRNA yes yes yes no no
EXP001817 Effective In Vivo Topical Delivery of siRNA and Gene Silencing in Intact Cornea… 2019 Chol-POD / siGLO topical eye drop siRNA yes yes no
EXP001818 Effective In Vivo Topical Delivery of siRNA and Gene Silencing in Intact Cornea… 2019 Palm-POD / siGLO topical eye drop siRNA yes yes no
EXP001819 Effective In Vivo Topical Delivery of siRNA and Gene Silencing in Intact Cornea… 2019 QN-Palm-POD / siGLO topical eye drop siRNA yes yes no
EXP001820 Effective In Vivo Topical Delivery of siRNA and Gene Silencing in Intact Cornea… 2019 QN-Palm-POD / siLuc topical eye drop (luciferase knockdown) siRNA no yes yes yes
EXP001821 Self-Assembling Peptide-Based Nanoparticles for siRNA Delivery in Primary Cell … 2012 CADY siRNA no yes no no
EXP001822 Self-Assembling Peptide-Based Nanoparticles for siRNA Delivery in Primary Cell … 2012 CADY siRNA no yes no no
EXP001823 Antibody-siRNA conjugates (ARCs) using multifunctional peptide as a tumor enzym… 2021 Ab-CPP-LSP-siRNA (cetuximab–PEG–LMWP–AANL–siRNA; ARC) siRNA yes yes no no
EXP001824 Antibody-siRNA conjugates (ARCs) using multifunctional peptide as a tumor enzym… 2021 CPP-LSP-siRNA (PEG–LMWP–AANL–siRNA; no antibody) siRNA yes yes no no
EXP001825 Antibody-siRNA conjugates (ARCs) using multifunctional peptide as a tumor enzym… 2021 CPP-LSP/siRNA physical mixture (LMWP-AANL + siRNA complex) siRNA yes yes no no
EXP001826 Antibody-siRNA conjugates (ARCs) using multifunctional peptide as a tumor enzym… 2021 Ab-CPP-MSP-siRNA (cetuximab–PEG–LMWP–GGPLGVR–siRNA; ARC) siRNA yes no no no
EXP001827 Antibody-siRNA conjugates (ARCs) using multifunctional peptide as a tumor enzym… 2021 Ab-CPP-siRNA (cetuximab–PEG–LMWP–siRNA; no substrate control) siRNA yes no no no
EXP001828 Antibody-siRNA conjugates (ARCs) using multifunctional peptide as a tumor enzym… 2021 Ab-CPP-LSP-siRNA-Cy3 (ARC; cetuximab–PEG–LMWP–AANL–siRNA) siRNA yes yes yes
EXP001829 Antibody-siRNA conjugates (ARCs) using multifunctional peptide as a tumor enzym… 2021 CPP-LSP-siRNA-Cy3 (PEG–LMWP–AANL–siRNA; no antibody) siRNA yes yes yes
EXP001830 Antibody-siRNA conjugates (ARCs) using multifunctional peptide as a tumor enzym… 2021 CPP-LSP-siRNA-Cy3/Ab physical mixture (noncovalent antibody addition) siRNA yes yes yes
EXP001831 Bi-specific splice-switching PMO oligonucleotides conjugated via a single pepti… 2015 Pip6a-PMO (Dmd exon23) single conjugate SCO no yes no no
EXP001832 Bi-specific splice-switching PMO oligonucleotides conjugated via a single pepti… 2015 Pip6a-PMO (Acvr2b exon5) single conjugate SCO no yes no no
EXP001833 Bi-specific splice-switching PMO oligonucleotides conjugated via a single pepti… 2015 Bi-specific D1 (one PMO on each Pip6a terminus) SCO no yes no no
EXP001834 Bi-specific splice-switching PMO oligonucleotides conjugated via a single pepti… 2015 Bi-specific D2 (both PMOs attached at Pip6a C-terminus; Acvr2b PMO click) SCO no yes no no
EXP001835 Bi-specific splice-switching PMO oligonucleotides conjugated via a single pepti… 2015 Bi-specific D3 (both PMOs attached at Pip6a C-terminus; Dmd PMO click) SCO no yes no no
EXP001836 Bi-specific splice-switching PMO oligonucleotides conjugated via a single pepti… 2015 Bi-specific D4 (C-terminal disulfide linkage for second PMO) SCO no yes no no
EXP001837 Bi-specific splice-switching PMO oligonucleotides conjugated via a single pepti… 2015 Bi-specific D2 (in vivo) SCO no yes yes
EXP001838 Bi-specific splice-switching PMO oligonucleotides conjugated via a single pepti… 2015 Bi-specific D3 (in vivo) SCO no yes yes
EXP001839 Bi-specific splice-switching PMO oligonucleotides conjugated via a single pepti… 2015 1:1 cocktail of single Pip6a-PMOs (Dmd + Acvr2b) (in vivo) SCO no yes yes
EXP001840 Cell-Penetrating Peptide-Modified Graphene Oxide Nanoparticles Loaded with Rict… 2021 Octaarginine (R8) siRNA yes yes no no
EXP001841 Cell-Penetrating Peptide-Modified Graphene Oxide Nanoparticles Loaded with Rict… 2021 Octaarginine (R8) siRNA no yes yes
EXP001842 Functional peptide nanocarriers for delivery of novel anti-RelA RNA interferenc… 2015 OK-102 (stearoyl-oligopeptide) ASO no yes no no
EXP001843 Functional peptide nanocarriers for delivery of novel anti-RelA RNA interferenc… 2015 OK-102 (stearoyl-oligopeptide) ASO no yes yes
EXP001844 Functional peptide nanocarriers for delivery of novel anti-RelA RNA interferenc… 2015 OK-102 (stearoyl-oligopeptide) ASO no yes no no
EXP001845 Functional peptide nanocarriers for delivery of novel anti-RelA RNA interferenc… 2015 OK-102 (stearoyl-oligopeptide) ASO no yes yes
EXP001846 Targeted Activation of Cystic Fibrosis Transmembrane Conductance Regulator 2019 HIV-1 Tat CPP (recombinant Tat peptide) ASO no yes no no
EXP001847 Targeted Activation of Cystic Fibrosis Transmembrane Conductance Regulator 2019 HIV-1 Tat CPP (recombinant Tat peptide) ASO no yes no no
EXP001848 Targeted Activation of Cystic Fibrosis Transmembrane Conductance Regulator 2019 HIV-1 Tat CPP (recombinant Tat peptide) ASO no yes no no
EXP001849 A blood–brain barrier- and blood–brain tumor barrier-penetrating siRNA delivery… 2024 Cholesterol-DP7-ACP-T7 (DAT) (dual-functional peptide on liposome) siRNA yes yes yes no no
EXP001850 A blood–brain barrier- and blood–brain tumor barrier-penetrating siRNA delivery… 2024 Cholesterol-DP7-ACP-T7 (DAT) (dual-functional peptide on liposome) siRNA no yes yes
EXP001851 A blood–brain barrier- and blood–brain tumor barrier-penetrating siRNA delivery… 2024 Cholesterol-DP7-ACP-T7 (DAT) peptide siRNA no yes no
EXP001852 A blood–brain barrier- and blood–brain tumor barrier-penetrating siRNA delivery… 2024 Cholesterol-DP7-PEG2-T7 peptide siRNA no yes no
EXP001853 A blood–brain barrier- and blood–brain tumor barrier-penetrating siRNA delivery… 2024 Cholesterol-DP7-Gly6-T7 peptide siRNA no yes no
EXP001854 A blood–brain barrier- and blood–brain tumor barrier-penetrating siRNA delivery… 2024 Cholesterol-T7-ACP-DP7 peptide siRNA no yes no
EXP001855 A blood–brain barrier- and blood–brain tumor barrier-penetrating siRNA delivery… 2024 Cholesterol-T7-PEG2-DP7 peptide siRNA no yes no
EXP001856 A blood–brain barrier- and blood–brain tumor barrier-penetrating siRNA delivery… 2024 Cholesterol-T7-Gly6-DP7 peptide siRNA no yes no
EXP001857 A blood–brain barrier- and blood–brain tumor barrier-penetrating siRNA delivery… 2024 Cholesterol-DP7-T7 peptide siRNA no yes no
EXP001858 siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma … 2020 Peptide 1 (Ala) siRNA yes no no no
EXP001859 siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma … 2020 Peptide 2 (Aib) siRNA yes no no no
EXP001860 siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma … 2020 Peptide 3 (Deg) siRNA yes no no no
EXP001861 siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma … 2020 Peptide 4 (Hms) siRNA yes no no no
EXP001862 siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma … 2020 Peptide 5 (Ac5c) siRNA yes no no no
EXP001863 siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma … 2020 Peptide 6 (Dpg) siRNA yes yes no no
EXP001864 A New Amphipathic, Amino-Acid-Pairing (AAP) Peptide as siRNA Delivery Carrier: … 2012 C6 siRNA yes no no no
EXP001865 Targeting glmS Ribozyme with Chimeric Antisense Oligonucleotides for Antibacter… 2021 pVEC ASO no yes no no
EXP001866 Targeting glmS Ribozyme with Chimeric Antisense Oligonucleotides for Antibacter… 2021 pVEC ASO no yes no no
EXP001867 Cell Targeting Peptide Conjugation to siRNA Polyplexes for Effective Gene Silen… 2012 PCM + Tat siRNA yes yes no no
EXP001868 Cell Targeting Peptide Conjugation to siRNA Polyplexes for Effective Gene Silen… 2012 PCM + Tat siRNA no yes no
EXP001869 Treatment of Colon Cancer by Degradable rrPPC Nano-Conjugates Delivered STAT3 s… 2020 cRGD-R9 siRNA yes yes no no
EXP001870 Treatment of Colon Cancer by Degradable rrPPC Nano-Conjugates Delivered STAT3 s… 2020 cRGD-R9 siRNA no yes yes
EXP001871 Establishment of MicroRNA Delivery System by PP7 Bacteriophage-Like Particles C… 2017 TAT miRNA yes yes no no
EXP001872 Cell-Penetrating Peptides Derived from Viral Capsid Proteins 2011 CP12-22 not reported yes no no
EXP001873 Cell-Penetrating Peptides Derived from Viral Capsid Proteins 2011 CP9-22 RNA, unspecified yes no no
EXP001874 Cell-Penetrating Peptides Derived from Viral Capsid Proteins 2011 CP9-22S not reported no no no
EXP001875 Cell-Penetrating Peptides Derived from Viral Capsid Proteins 2011 CPNT RNA, unspecified yes yes no no
EXP001876 Cell-Penetrating Peptides Derived from Viral Capsid Proteins 2011 CP23-34 not reported no no no
EXP001877 Targeted OUM1/PTPRZ1 silencing and synergetic CDT/enhanced chemical therapy tow… 2022 RGD siRNA yes yes no no
EXP001878 Targeted OUM1/PTPRZ1 silencing and synergetic CDT/enhanced chemical therapy tow… 2022 RGD siRNA no yes yes
EXP001879 Improved method for synthesis of low molecular weight protamine–siRNA conjugate 2018 LMWP siRNA yes yes no no
EXP001880 Highly penetrating nanobubble polymer enhances LINC00511-siRNA delivery for imp… 2021 TAT (CPP) siRNA yes yes no no
EXP001881 Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Dockin… 2017 Penetratin siRNA no no no
EXP001882 Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Dockin… 2017 HIV-TAT (47–57) siRNA no no no
EXP001883 Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Dockin… 2017 R10 siRNA no no no
EXP001884 Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Dockin… 2017 CCMV Gag (7–25) siRNA no no no
EXP001885 Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Dockin… 2017 S413-PV siRNA no no no
EXP001886 Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Dockin… 2017 Transportan siRNA no no no
EXP001887 Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Dockin… 2017 pVEC siRNA no no no
EXP001888 Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Dockin… 2017 MPG siRNA no no no
EXP001889 Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Dockin… 2017 CADY siRNA no no no
EXP001890 Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Dockin… 2017 sC18 siRNA no no no
EXP001891 Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Dockin… 2017 C6 siRNA no no no
EXP001892 Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Dockin… 2017 K-FGF siRNA no no no
EXP001893 Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Dockin… 2017 Integrin β3 fragment siRNA no no no
EXP001894 Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Dockin… 2017 HBV translocation motif siRNA no no no
EXP001895 Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Dockin… 2017 Grb2 (SH2 domain) siRNA no no no
EXP001896 Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Dockin… 2017 HIV-1 gp41 (1–23) siRNA no no no
EXP001897 Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Dockin… 2017 C105Y siRNA no no no
EXP001898 TAT Peptides Mediated Small Interfering RNA Delivery to Huh-7 Cells and Efficie… 2009 HIV-1 TAT 47–57 siRNA yes yes no no
EXP001899 Tumor pH-functionalized and charge-tunable nanoparticles for the nucleus/cytopl… 2022 T-peptide (TAT–NGR) miRNA yes yes yes no no
EXP001900 Tumor pH-functionalized and charge-tunable nanoparticles for the nucleus/cytopl… 2022 T-peptide (TAT–NGR) miRNA yes yes yes yes

First Previous 1 ... 17 18 19 20 21 ... 26 Next Last